tirzepatide and tamoxifen Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes weight loss (Mounjaro, Zepbound)—can also shrink breast cancer tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Highlighting 3 ongoing clinical trials
Description
But when it comes to satisfying key consumer trends, two major stumbling blocks are holding the market back: its difficult to add lots of protein without a negative impact on texture, and its tricky to create cereal bars that are not high in sugar.
Cellulite causes and ways to get rid of cellulite
Nausea is a common early side effect of semaglutide therapy that typically peaks in the first 2-4 weeks and improves as your body adjusts
Whether a company manufactures products synthetically often depends on its current capabilities
